These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 33498186
21. Metals in ALS TDP-43 Pathology. Koski L, Ronnevi C, Berntsson E, Wärmländer SKTS, Roos PM. Int J Mol Sci; 2021 Nov 11; 22(22):. PubMed ID: 34830074 [Abstract] [Full Text] [Related]
22. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW. Gois AM, Mendonça DMF, Freire MAM, Santos JR. Brain Res Bull; 2020 Jun 11; 159():32-43. PubMed ID: 32247802 [Abstract] [Full Text] [Related]
23. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. Karch CM, Wen N, Fan CC, Yokoyama JS, Kouri N, Ross OA, Höglinger G, Müller U, Ferrari R, Hardy J, Schellenberg GD, Sleiman PM, Momeni P, Hess CP, Miller BL, Sharma M, Van Deerlin V, Smeland OB, Andreassen OA, Dale AM, Desikan RS, International Frontotemporal Dementia (FTD)–Genomics Consortium, International Collaboration for Frontotemporal Dementia, Progressive Supranuclear Palsy (PSP) Genetics Consortium, and International Parkinson’s Disease Genomics Consortium. JAMA Neurol; 2018 Jul 01; 75(7):860-875. PubMed ID: 29630712 [Abstract] [Full Text] [Related]
24. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carrì MT, Volonté C. J Immunol; 2009 Oct 01; 183(7):4648-56. PubMed ID: 19734218 [Abstract] [Full Text] [Related]
30. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation. Liu J, Allender E, Wang J, Simpson EH, Loeb JA, Song F. Neurobiol Dis; 2018 Mar 15; 111():118-126. PubMed ID: 29278738 [Abstract] [Full Text] [Related]
33. A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis. Srinivasan E, Rajasekaran R. J Mol Neurosci; 2020 Nov 15; 70(11):1742-1770. PubMed ID: 32415434 [Abstract] [Full Text] [Related]
34. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Cox LM, Calcagno N, Gauthier C, Madore C, Butovsky O, Weiner HL. Microbiome; 2022 Mar 11; 10(1):47. PubMed ID: 35272713 [Abstract] [Full Text] [Related]
35. Protein folding alterations in amyotrophic lateral sclerosis. Parakh S, Atkin JD. Brain Res; 2016 Oct 01; 1648(Pt B):633-649. PubMed ID: 27064076 [Abstract] [Full Text] [Related]
36. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis. Parakh S, Jagaraj CJ, Vidal M, Ragagnin AMG, Perri ER, Konopka A, Toth RP, Galper J, Blair IP, Thomas CJ, Walker AK, Yang S, Spencer DM, Atkin JD. Hum Mol Genet; 2018 Apr 15; 27(8):1311-1331. PubMed ID: 29409023 [Abstract] [Full Text] [Related]
37. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Bursch F, Kalmbach N, Naujock M, Staege S, Eggenschwiler R, Abo-Rady M, Japtok J, Guo W, Hensel N, Reinhardt P, Boeckers TM, Cantz T, Sterneckert J, Van Den Bosch L, Hermann A, Petri S, Wegner F. Hum Mol Genet; 2019 Sep 01; 28(17):2835-2850. PubMed ID: 31108504 [Abstract] [Full Text] [Related]